A Study Of Pharmacokinetics, Pharmacodynamics And Safety Of Adding ETC-1002 To Atorvastatin 80 mg
Status:
Completed
Trial end date:
2016-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this research study is to measure the amount of atorvastatin and ETC-1002 in
the blood, to determine how ETC-1002 affects the level of LDL-cholesterol (bad cholesterol)
and other markers of health and disease in blood and urine, and to see how ETC-1002 is
tolerated in the body compared to placebo when added to stable atorvastatin 80 mg background
therapy in statin-treated patients.